GLP-1 Medications Vs
Common side effects include: Constipation Decreased appetite Diarrhea Nausea Vomiting Researchers reported that these side effects were usually mild to moderate and most commonly occurred during the dose-escalation phase of treatment
The medication works by mimicking the incretin hormone GLP-1, which stimulates insulin secretion, suppresses glucagon release, and slows gastric emptying
Register your interest in Retatrutide Retatrutide is currently not available, but once it is approved, youll be the first to get notified
NIDDK notes that these medications reduce appetite and slow gastric emptying, which together can support clinically meaningful weight reduction
Polyendocrine metabolic ovarian syndrome isnt yet an official FDA indication for any GLP-1 medications, but clinicians are increasingly using the drugs for women with the condition, which is closely tied to insulin resistance and weight